68
Views
0
CrossRef citations to date
0
Altmetric
Preliminary Communication

Formulation Buoyancy of Nanoencapsulated Gliclazide Using primary, Conjugated and Deconjugated Bile Acids

, , , , , , & show all
Pages 573-583 | Received 10 Aug 2019, Accepted 02 Oct 2019, Published online: 24 Oct 2019

References

  • Green JL , AndersonV , DartRC , HeardK. Medication history assessment in research: a randomized controlled trial comparing tablet-based (eMedHAT) versus structured interview (MedHAT). Pharmacoepidemiol. Drug Saf.27(12), 1356–1360 (2018).
  • Orive G , HernandezRM , GasconARet al. Cell encapsulation: promise and progress. Nat. Med.9(1), 104–107 (2003).
  • Orive G , HernandezRM , RodriguezGascon Aet al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol.22(2), 87–92 (2004).
  • Abdelallah NH , AbdeltawabNF , BoseilaAA , AminMA. Chitosan and sodium alginate combinations are alternative, efficient and safe natural adjuvant systems for Hepatitis B vaccine in mouse model. Evid. Based Complement. Alternat. Med.2016, 7659684 (2016).
  • Mooranian A , NegruljR , JamiesonE , MorahanG , Al-SalamiH. Biological assessments of encapsulated pancreatic β-cells: their potential transplantation in diabetes. Cell. Mol. Bioeng.9(4), 530–537 (2017).
  • Mooranian A , ZamaniN , TakechiRet al. Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of Type 1 diabetes. Artif. Cells Nanomed. Biotechnol.46, 748–754 (2018).
  • Mooranian A , ZamaniN , MikovMet al. Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatment. Ther. Deliv.10(2), 99–106 (2019).
  • Whelehan M , MarisonIW. Microencapsulation using vibrating technology. J. Microencapsul.28(8), 669–688 (2011).
  • Wang L , LiuY , PuF , ZhangW , ZhouZ. Effect of rotary evaporator water bath temperature on recovery rate of phthalate esters. Bull. Environ. Contam. Toxicol.101(6), 810–813 (2018).
  • Sapra M , MayyaYS , VenkataramanC. Engineering of layered, lipid-encapsulated drug nanoparticles through spray-drying. Colloids Surf. B. Biointerfaces154, 178–185 (2017).
  • Houten SM , WatanabeM , AuwerxJ. Endocrine functions of bile acids. EMBO J.25(7), 1419–1425 (2006).
  • Lalic-Popovic M , VasovicV , MilijasevicB , Golocorbin-KonS , Al-SalamiH , MikovM. Deoxycholic acid as a modifier of the permeation of gliclazide through the blood brain barrier of a rat. J. Diabetes Res.2013, 598603 (2013). doi:10.1155/2013/598603
  • Mathavan S , Chen-TanN , ArfusoF , Al-SalamiH. A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes. Drug Deliv.23(8), 2869–2880 (2016).
  • Mathavan S , Chen-TanN , ArfusoF , Al-SalamiH. The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in Type 1 diabetes. Artif. Cells Nanomed. Biotechnol.44(6), 1508–1519 (2016).
  • Mooranian A , NegruljR , MathavanSet al. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J. Pharm. Innov.9(2), 150–157 (2014).
  • Mooranian A , NegruljR , TakechiR , JamiesonE , MorahanG , Al-SalamiH. New biotechnological microencapsulating methodology utilizing individualized gradient-screened jet laminar flow techniques for pancreatic beta-cell delivery: bile acids support cell energy-generating mechanisms. Mol. Pharm.14(8), 2711–2718 (2017).
  • Sánchez L , SánchezP , DeLucas A , CarmonaM , RodríguezJF. Microencapsulation of PCMs with a polystyrene shell. Colloid Polym. Sci.285(12), 1377–1385 (2007).
  • Al-Salami H , ButtG , TuckerI , MikovM. Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Pharmacol. Rep.60(4), 532–541 (2008).
  • Al-Salami H , ButtG , TuckerI , SkrbicR , Golocorbin-KonS , MikovM. Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Arch. Drug Inf.1(1), 35–41 (2008).
  • Al-Salami H , ButtG , TuckerI , Golocorbin-KonS , MikovM. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet.37(2), 99–108 (2012).
  • Mooranian A , TakechiR , JamiesonE , MorahanG , Al-SalamiH. The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic beta-cells: biomaterials, osmotic forces and potential applications in diabetes treatment. Pharm. Dev. Technol.23(2), 145–150 (2018).
  • Mooranian A , NegruljR , Chen-TanNet al. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Des. Devel. Ther.8, 1003–1012 (2014).
  • Mooranian A , NegruljR , Chen-TanN , WattsGF , ArfusoF , Al-SalamiH. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Des. Devel. Ther.8, 1673–1683 (2014).
  • Almutairy BK , AlshetailiAS , AshourEAet al. Development of a floating drug delivery system with superior buoyancy in gastric fluid using hot-melt extrusion coupled with pressurized CO2. Pharmazie71(3), 128–133 (2016).
  • Yom-Tov O , SeliktarD , Bianco-PeledH. A modified emulsion gelation technique to improve buoyancy of hydrogel tablets for floating drug delivery systems. Mater. Sci. Eng. C Mater. Biol. Appl.55, 335–342 (2015).
  • Hong SS , LeeSH , LeeYJ , ChungSJ , LeeMH , ShimCK. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide. J. Control. Rel.51(2-3), 185–192 (1998).
  • Pal D , NayakAK. Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules. AAPS PharmSciTech.12(4), 1431–1441 (2011).
  • Prajapati SK , TripathiP , UbaidullaU , AnandV. Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation. AAPS PharmSciTech.9(1), 224–230 (2008).
  • Tsiani E , RamlalT , LeiterL , KlipA , FantusI. Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide. Endocrinology136(6), 2505–2512 (1995).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.